JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 14 No. 5 265-268
© 1973 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jhingran, S. G.
Right arrow Articles by Johnson, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jhingran, S. G.
Right arrow Articles by Johnson, P. C.

Radionuclide Angiography in the Diagnosis of Cerebrovascular Disease

Satish G. Jhingran and Philip C. Johnson

Baylor College of Medicine, Houston, Texas and the Methodist Hospital

Correspondence: For reprints contact: Philip C. Johnson, Dept. of Internal Medicine, Baylor College of Medicine, Texas Medical Center, Houston, Tex. 77025.

ABSTRACT

A comparison between radiocontrast and radionuclide angiography was made in 272 patients with cerebrovascular disease. The radionuclide studies showed a 58% true-positive rate and 11% false-positive rate. The true-positive rate for patients with unilateral carotid artery disease was 66%. These results were similar to those of other reported series (63% true positive and 11% false positive). Therefore, radionuclide angiography is not recommended as the major screening procedure in cerebrovascular disease.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1973 by the Society of Nuclear Medicine.